
Overview
Background
Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.
Availability
- Professor Gabrielle Belz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Veterinary Biology, The University of Queensland
- Bachelor (Honours) of Veterinary Science, The University of Queensland
- Doctor of Philosophy, The University of Queensland
- Doctoral Diploma, The University of Queensland
Research impacts
Overall goals:
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites.
We are elucidating how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another.
Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Research interests:
Cell differentiation is the process by which cells develop and mature. In this process, cells become more specialised and acquire potent effector functions that allow them to eliminate infectious organisms. There is an urgent need to develop new therapies that focus on augmenting host immunity.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory.
We have developed and use a number of in vivo models of infectious diseases including:
- Influenza
- Herpes virus
- Lymphocytic choriomeningitis virus (LCMV)
These models provide us with an unprecedented opportunity to examine the mechanisms that these pathogens employ to infect hosts and elicit immune protection or to subvert the host responses. Using a variety of approaches including multiparameter flow cytometry, systems biology and global gene expression profiling we aim to define cellular and transcriptional pathways in normal memory T cell differentiation, innate immune cell subsets and immune failure.
Works
Search Professor Gabrielle Belz’s works on UQ eSpace
2012
Journal Article
Alternative splicing of Bim and Erk-mediated Bim<sub>EL</sub> phosphorylation are dispensable for hematopoietic homeostasis <i>in vivo</i>
Clybouw, C., Merino, D., Nebl, T., Masson, F., Robati, M., O'Reilly, L., Huebner, A., Davis, R. J., Strasser, A. and Bouillet, P. (2012). Alternative splicing of Bim and Erk-mediated BimEL phosphorylation are dispensable for hematopoietic homeostasis in vivo. Cell Death and Differentiation, 19 (6), 1060-1068. doi: 10.1038/cdd.2011.198
2012
Journal Article
ISCOMATRIX vaccines mediate CD8 T-cell cross-priming by a MyD88-dependent signaling pathway
Wilson, Nicholas S., Yang, Becky, Morelli, Adriana Baz, Koernig, Sandra, Yang, Annie, Loeser, Stefanie, Airey, Denise, Provan, Larissa, Hass, Phil, Braley, Hal, Couto, Suzana, Drane, Debbie, Boyle, Jeff, Belz, Gabrielle T., Ashkenazi, Avi and Maraskovsky, Eugene (2012). ISCOMATRIX vaccines mediate CD8 T-cell cross-priming by a MyD88-dependent signaling pathway. Immunology and Cell Biology, 90 (5), 540-552. doi: 10.1038/icb.2011.71
2012
Journal Article
The development and fate of follicular helper T cells defined by an IL-21 reporter mouse
Lüthje, Katja, Kallies, Axel, Shimohakamada, Yoko, Belz, Gabrielle T., Light, Amanda, Tarlinton, David M. and Nutt, Stephen L. (2012). The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nature Immunology, 13 (5), 491-498. doi: 10.1038/ni.2261
2012
Journal Article
Activated mouse B cells lack expression of granzyme B
Hagn, Magdalena, Belz, Gabrielle T., Kallies, Axel, Sutton, Vivien R., Thia, Kevin Y., Tarlinton, David M., Hawkins, Edwin D. and Trapani, Joseph A. (2012). Activated mouse B cells lack expression of granzyme B. Journal of Immunology, 188 (8), 3886-3892. doi: 10.4049/jimmunol.1103285
2012
Journal Article
The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties
Gugasyan, Raffi, Horat, Elisha, Kinkel, Sarah A., Ross, Fiona, Grigoriadis, George, Gray, Daniel, O'Keeffe, Meredith, Berzins, Stuart P., Belz, Gabrielle T., Grumont, Raelene J., Banerjee, Ashish, Strasser, Andreas, Godfrey, Dale I., Tsichlis, Philip N. and Gerondakis, Steve (2012). The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties. EMBO Journal, 31 (3), 692-706. doi: 10.1038/emboj.2011.435
2012
Journal Article
Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation
Hardy, Charles L., LeMasurier, Jeanne S., Belz, Gabrielle T., Scalzo-Inguanti, Karen, Yao, Jun, Xiang, Sue D., Kanellakis, Peter, Bobik, Alex, Strickland, Deborah H., Rolland, Jennifer M., O'Hehir, Robyn E. and Plebanski, Magdalena (2012). Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. Journal of Immunology, 188 (3), 1431-1441. doi: 10.4049/jimmunol.1100156
2012
Journal Article
Transcriptional programming of the dendritic cell network
Belz, Gabrielle T. and Nutt, Stephen L. (2012). Transcriptional programming of the dendritic cell network. Nature Reviews Immunology, 12 (2), 101-113. doi: 10.1038/nri3149
2012
Conference Publication
4th Australasian vaccines and immunotherapeutic development meeting
Engwerda, Christian and Belz, Gabrielle (2012). 4th Australasian vaccines and immunotherapeutic development meeting. 4th Australasian vaccines and immunotherapeutic development meeting, Oxford, United Kingdom: John Wiley & Sons. doi: 10.1038/icb.2012.55
2012
Journal Article
Immunology and Cell Biology Publication of the Year Awards 2011
Belz, Gabrielle T. (2012). Immunology and Cell Biology Publication of the Year Awards 2011. Immunology and Cell Biology, 90 (8), 749-750. doi: 10.1038/icb.2012.41
2011
Journal Article
Murid Herpesvirus-4 Exploits Dendritic Cells to Infect B Cells.
Gaspar, Miguel, May, Janet S., Sukla, Soumi, Frederico, Bruno, Gill, Michael B., Smith, Christopher M., Belz, Gabrielle T. and Stevenson, Philip G. (2011). Murid Herpesvirus-4 Exploits Dendritic Cells to Infect B Cells.. PLoS Pathogens, 7 (11) e1002346, e1002346-e1002346. doi: 10.1371/journal.ppat.1002346
2011
Journal Article
Modeling of influenza-specific CD8 + T cells during the primary response indicates that the spleen is a major source of effectors
Wu, Hulin, Kumar, Arun, Miao, Hongyu, Holden-Wiltse, Jeanne, Mosmann, Timothy R., Livingstone, Alexandra M., Belz, Gabrielle T., Perelson, Alan S., Zand, Martin S. and Topham, David J. (2011). Modeling of influenza-specific CD8 + T cells during the primary response indicates that the spleen is a major source of effectors. Journal of Immunology, 187 (9), 4474-4482. doi: 10.4049/jimmunol.1101443
2011
Journal Article
Immunology and Cell Biology publication of the year awards 2010
Belz, Gabrielle T. (2011). Immunology and Cell Biology publication of the year awards 2010. Immunology and Cell Biology, 89 (7), 747-748. doi: 10.1038/icb.2011.77
2011
Journal Article
Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages
Jackson, Jacob T., Hu, Yifang, Liu, Ruijie, Masson, Frederick, D'Amico, Angela, Carotta, Sebastian, Xin, Annie, Camilleri, Mary J., Mount, Adele M., Kallies, Axel, Wu, Li, Smyth, Gordon K., Nutt, Stephen L. and Belz, Gabrielle T. (2011). Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages. EMBO Journal, 30 (13), 2690-2704. doi: 10.1038/emboj.2011.163
2011
Journal Article
Out-of-the-box thinking
Belz, Gabrielle T. (2011). Out-of-the-box thinking. Immunology and Cell Biology, 89 (5), 575-575. doi: 10.1038/icb.2011.57
2011
Journal Article
Identification of the earliest NK-cell precursor in the mouse BM
Carotta, Sebastian, Pang, Swee Heng Milon, Nutt, Stephen L. and Belz, Gabrielle T. (2011). Identification of the earliest NK-cell precursor in the mouse BM. Blood, 117 (20), 5449-5452. doi: 10.1182/blood-2010-11-318956
2011
Journal Article
The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses
Seah, Shirley G. K., Sutherland, Robyn M., La Gruta, Nicole L., Brown, Lorena E., Carrington, Emma M., Belz, Gabrielle T., Brady, Jamie L., Turner, Stephen J., Zhan, Yifan and Lew, Andrew M. (2011). The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses. European Journal of Immunology, 41 (5), 1499-1500. doi: 10.1002/eji.201141399
2011
Journal Article
Diverse roles of inhibitor of differentiation2 in adaptive immunity
Belz, Gabrielle T. and Rankin, Lucille (2011). Diverse roles of inhibitor of differentiation2 in adaptive immunity. Clinical and Developmental Immunology, 2011 281569, 1-11. doi: 10.1155/2011/281569
2011
Journal Article
The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells
Cretney, Erika, Xin, Annie, Shi, Wei, Minnich, Martina, Masson, Frederick, Miasari, Maria, Belz, Gabrielle T., Smyth, Gordon K., Busslinger, Meinrad, Nutt, Stephen L. and Kallies, Axel (2011). The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nature Immunology, 12 (4), 304-312. doi: 10.1038/ni.2006
2011
Journal Article
Bid and Bim collaborate during induction of T cell death in persistent infection
Masson, Frederick, Kupresanin, Fiona, Mount, Adele, Strasser, Andreas and Belz, Gabrielle T. (2011). Bid and Bim collaborate during induction of T cell death in persistent infection. Journal of Immunology, 186 (7), 4059-4066. doi: 10.4049/jimmunol.1001918
2011
Conference Publication
Blimp1: Driving terminal differentiation to a T
Xin, Annie, Nutt, Stephen L., Belz, Gabrielle T. and Kallies, Axel (2011). Blimp1: Driving terminal differentiation to a T. Aegean Conference: 3rd Crossroads between innate and adaptive immunity, Chania, Crete, Greece, 27 September - October 2, 2009. New York, NY, United States: Springer. doi: 10.1007/978-1-4419-5632-3_8
Funding
Current funding
Supervision
Availability
- Professor Gabrielle Belz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Understanding mucosal immunity
The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.
-
Delineating long-term protective immunity to pathogen infection
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory
-
Understanding mucosal immunity
The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.
-
Delineating long-term protective immunity to pathogen infection
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory
-
Unravelling immune signalling networks in mucosal immunity
Mucosal surfaces are critical interfaces where host-environment interactions occur, and the interplay between epithelial cells and immune components is essential for balancing tolerance and immunity. Disruptions to mucosal barrier integrity have profound consequences, contributing to the onset and progression of numerous diseases. Moreover, mucosal surfaces are key entry points for pathogens, including emerging viral threats, making a robust barrier indispensable for preventing infection. Despite the importance of this barrier, our understanding of how it is regulated and integrates signals from the microbiome to the immune cells is poorly understood.
This exciting opportunity aims to unravel the intricate interactions between immune cells and epithelial tissues, with a focus on understanding their roles in maintaining barrier integrity and immune homeostasis in mucosal environments such as the gut, lungs, and skin. This project will investigate how epithelial cells communicate with innate and adaptive immune cells to modulate responses to microbial, dietary, and environmental stimuli.
Utilizing cutting-edge approaches including advanced imaging, organoid co-culture systems, multiomics, and animal models, the candidate will uncover molecular mechanisms that underpin immune-epithelial cross-talk. The findings will unravel new knowledge that sets the foundation for the development of new strategies for diseases such as inflammatory bowel disease, asthma, and other epithelial barrier disorders.
The Belz Laboratory
The successful candidate will join a dynamic and interdisciplinary research team in a supportive academic environment. Our team is composed of highly collaborative passionate post-doctoral scientists, research assistants and PhD students with diverse backgrounds. We have expertise in state-of the art imaging, multi-dimensional flow cytometry and mucosal immunology. We provide a unique, collaborative environment and opportunity to develop diverse skill-sets and make impactful discoveries.
Frazer Institute at the University of Queensland
The Frazer Institute at the University of Queensland offers a dynamic and collaborative research environment dedicated to advancing biomedical innovation. Situated in Brisbane, a vibrant and rapidly growing hub for science and technology, the Institute provides access to world-class facilities and resources in a stunning subtropical setting.
As a leading research centre, the Frazer Institute fosters interdisciplinary collaboration, bringing together experts in immunology, molecular biology, and translational medicine. Its strategic partnerships with hospitals, biotech industries, and global research networks enable researchers to translate discoveries into real-world applications.
The Institute is equipped with state-of-the-art technologies, including single-cell genomics, high-resolution imaging, organoid platforms, and advanced proteomics. These cutting-edge tools empower researchers to explore complex biological questions with unprecedented precision.
With its emphasis on mentorship, innovation, and impact-driven research, the Frazer Institute offers exceptional opportunities for scientists aiming to contribute to transformative discoveries in health and medicine.
The Frazer Institute is committed to diversity and equal opportunity and the development of emerging researchers at the highest level.
Supervision history
Current supervision
-
Doctor Philosophy
Studying the tumour immune microenvironment in cutaneous squamous cell carcinoma
Principal Advisor
Other advisors: Associate Professor Arutha Kulasinghe
-
Doctor Philosophy
Understanding Key Epithelial Cells Following Lung Infection
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Understanding Key Epithelial Cells Following Lung Infection
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Deciphering the protective program of innate and adaptive cells in pathogen infection
Principal Advisor
Other advisors: Associate Professor Timothy Wells
-
Doctor Philosophy
High Mobility Group Box Family Member TOX2 in Innate Lymphoid Cell Development and Maintenance
Principal Advisor
Other advisors: Associate Professor Timothy Wells
-
Doctor Philosophy
The role of innate cells in shaping the tumour environment.
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes, Dr M. Zeeshan Chaudhry
-
Doctor Philosophy
Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection
Principal Advisor
Other advisors: Professor Mark Walker
-
Doctor Philosophy
Innate lymphoid cells in tumour control
Principal Advisor
-
Doctor Philosophy
Immune Regulation of Lung Injury: Pathways to Repair, Restoration and Fibrosis
Principal Advisor
Other advisors: Professor Dan Chambers
-
Doctor Philosophy
Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection
Principal Advisor
Other advisors: Professor Mark Walker
-
Doctor Philosophy
Development of natural killer cells with enhanced tumoricidal functions using CRISPR homology-directed repair-mediated gene editing
Associate Advisor
Other advisors: Dr Allie Lam, Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Understanding immune diversity in skin inflammation
Associate Advisor
Other advisors: Professor Kiarash Khosrotehrani, Dr Snehlata Kumari
-
Doctor Philosophy
The Ins and Outs of Endocytosis inhibition: Providing diverse opportunities for treatment of incurable cancers
Associate Advisor
Other advisors: Dr Shannon Joseph, Professor Fiona Simpson
-
Doctor Philosophy
Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection
Associate Advisor
Other advisors: Dr Nichaela Harbison-Price, Professor Mark Walker
Completed supervision
Media
Enquiries
For media enquiries about Professor Gabrielle Belz's areas of expertise, story ideas and help finding experts, contact our Media team: